Business

Contract win in growing eCOA revenue stream

Contract win in growing eCOA revenue stream.

articleCambridge Cognition Holdings PlcNovember 14, 20185/company/cambridge-cognition-holdings-plc/news/contract-win-in-growing-ecoa-revenue-stream
Contract win in growing eCOA revenue stream

About this update from Cambridge Cognition Holdings Plc

[{"type":"text","content":"\n \nRNS Number : 2437H Cambridge Cognition Holdings PLC 14 November 2018  \n\nCambridge Cognition Holdings Plc\n('Cambridge Cognition' or the 'Company')\n \nContract win in growing eCOA revenue stream\n \nCambridge Cognition Holdings plc (AIM: COG), which develops and markets neuroscience technology to assess brain health, today announced it has won a significant new clinical trial contract, which is the largest in a series of recently signed electronic clinical outcomes assessment (eCOA) trials.\nThe contract is worth over US$750,000 with a new client for the Company, a specialty pharmaceutical developer, over a one-year period. It is the largest of a number of eCOA contracts won since Cambridge Cognition decided to increase the value of its software service by expanding the capabilities of its CANTAB Connect platform. The technology now enables the assessment of multiple outcomes, in addition to cognitive measures, on a single platform.\nThis latest contract is for a phase IV trial which will use the Company's robust eCOA technology to evaluate treatment safety and tolerability with objective computerised cognitive assessments and additional clinician-reported outcome measures delivered to patients on touchscreen devices.\nPerforming multiple outcome assessments on the validated CANTAB Connect platform integrates data collection, reduces administrative burden and saves costs for study sites while improving data quality throughout the trial.\nDr Steven Powell, Chief Executive Officer, Cambridge Cognition said: \"We are pleased to welcome another pharmaceutical partner to the growing number who trust our neuroscience technologies with the collection and analysis of valuable patient data. In 2018 we took the strategic decision, based on customer input, to enable clients to mitigate risks and reduce operational costs by measuring more outcomes on our proven CANTAB Connect platform. This series of recent contract wins further validates the Company's strategy and demonstrates our ability to translate customer requirements into revenue rapidly.\"\n \nEnquiries\n \n\n\n\nCambridge Cognition Holdings PLC\nSteven Powell, Chief Executive Officer\nNoah Konig, Director of Marketing \n\n\n \nTel: 01223 810 700\[email protected]\n\n\n\n\nfinnCap Ltd (NOMAD and Joint Broker)\nGeoff Nash / Simon Hicks\nAlice...

More updates from Cambridge Cognition Holdings Plc